POSTER: AML-1153: Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos, Andrew Lane, Luca Mazzarella, David Sallman, Matthew Ulrickson, Gary Schiller, Harry Erba, Eunice Wang, Roland Walter, Eric Deconinck, Ahmed Aribi, Delphine Lebon, Valerio Maisano, Daniel Deangelo, Enrico Derenzini, Yulei He, Rebecca Reindel, Nisha Kishore, Jalaja Potluri, Hagop Kantarjian, Naval Daver

Open source

DOI: 10.1016/s2152-2650(26)00584-7
Published: 2026-09-09
Container: Not recorded
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2152-2650-26-00584-7,
  title = {POSTER: AML-1153: Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm},
  author = {Naveen Pemmaraju and Giovanni Marconi and Pau Montesinos and Andrew Lane and Luca Mazzarella and David Sallman and Matthew Ulrickson and Gary Schiller and Harry Erba and Eunice Wang and Roland Walter and Eric Deconinck and Ahmed Aribi and Delphine Lebon and Valerio Maisano and Daniel Deangelo and Enrico Derenzini and Yulei He and Rebecca Reindel and Nisha Kishore and Jalaja Potluri and Hagop Kantarjian and Naval Daver},
  year = {2026},
  doi = {10.1016/s2152-2650(26)00584-7},
  url = {https://doi.org/10.1016/s2152-2650(26)00584-7}
}

RIS

TY  - JOUR
TI  - POSTER: AML-1153: Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
AU  - Naveen Pemmaraju
AU  - Giovanni Marconi
AU  - Pau Montesinos
AU  - Andrew Lane
AU  - Luca Mazzarella
AU  - David Sallman
AU  - Matthew Ulrickson
AU  - Gary Schiller
AU  - Harry Erba
AU  - Eunice Wang
AU  - Roland Walter
AU  - Eric Deconinck
AU  - Ahmed Aribi
AU  - Delphine Lebon
AU  - Valerio Maisano
AU  - Daniel Deangelo
AU  - Enrico Derenzini
AU  - Yulei He
AU  - Rebecca Reindel
AU  - Nisha Kishore
AU  - Jalaja Potluri
AU  - Hagop Kantarjian
AU  - Naval Daver
PY  - 2026
DO  - 10.1016/s2152-2650(26)00584-7
UR  - https://doi.org/10.1016/s2152-2650(26)00584-7
ER  -

APA

Pemmaraju, N., Marconi, G., Montesinos, P., Lane, A., Mazzarella, L., Sallman, D., Ulrickson, M., Schiller, G., Erba, H., Wang, E., Walter, R., Deconinck, E., Aribi, A., Lebon, D., Maisano, V., Deangelo, D., Derenzini, E., He, Y., Reindel, R., Kishore, N., Potluri, J., Kantarjian, H., & Daver, N. (2026). POSTER: AML-1153: Characterization of Edema Adverse Events in the CADENZA Study of Pivekimab Sunirine in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. https://doi.org/10.1016/s2152-2650(26)00584-7

Source records

hal · retrieved 2026-09-25T21:27:02.602Z